首页 > 最新文献

Journal of Genetic Counseling最新文献

英文 中文
Navigating sexual orientation and gender identity data privacy concerns in United States genetics practices
IF 1.9 4区 医学 Q3 GENETICS & HEREDITY Pub Date : 2025-03-08 DOI: 10.1002/jgc4.70008
Kimberly Zayhowski, Sarah Roth, M. J. Westerfield, Makenna A. Martin, Kai Blumen, Harris T. Bland, Shelly W. McQuaid, Kathleen F. Mittendorf
<p>Recent federal efforts, such as those by the Centers for Medicare & Medicaid Services, have expanded sexual orientation and gender identity (SOGI) data collection to improve healthcare equity, and several states mandate regular SOGI data collection in healthcare (examples in Hunter, <span>2021</span>; Oregon Health Authority, <span>2023</span>; Tsai, <span>2023</span>). Best practice recommendations in genetics healthcare also encourage SOGI data collection (Bland et al., <span>2024</span>; Jamal et al., <span>2024</span>). SOGI data allow the provision of accurate, culturally responsive genetics care. For example, healthcare professionals' (HCP) knowledge of patients' gender-affirming care facilitates accurate cancer risk assessments and management (Cortina et al., <span>2024</span>; Roth et al., <span>2024</span>; von Vaupel-Klein & Walsh, <span>2021</span>). Moreover, HCPs respecting patients' identities and family structures promotes trust and psychological safety (Call et al., <span>2021</span>; Huser et al., <span>2022</span>; McCann & Brown, <span>2018</span>; Roth et al., <span>2024</span>).</p><p>However, as we enter the second Trump administration, SOGI data documentation has concerning implications in the United States socio-political landscape. The previous Trump administration enacted overtly anti-LGBTQ+ (lesbian, gay, bisexual, transgender, queer/questioning, etc.) policies, including banning transgender and gender diverse (TGD) individuals from military service, attempting to define gender strictly based on sex assigned at birth, and rolling back LGBTQ+ patient protections granted during the Obama administration (Green et al., <span>2018</span>; Memorandum on Military Service by Transgender Individuals, <span>2017</span>; Nondiscrimination in Health and Health Education Programs or Activities, Delegation of Authority, 45 CFR 92, <span>2020</span>). Despite re-expansion of LBGTQ+ federal legislative protections under the Biden administration, far-right anti-LGBTQ+ legislation has increased at the state level (American Civil Liberties Union, <span>2024</span>; Restar et al., <span>2024</span>). The 2024 Trump campaign and those of allied Congressional candidates promised additional anti-TGD policies, with Republicans spending over $222 million dollars on anti-TGD and anti-LGBTQ advertisements during this time (Simmons-Duffin, <span>2024</span>). The Trump administration is expected to prioritize policies targeting TGD individuals early in its tenure, as highlighted in its “Agenda 47” platform, with points including cutting funding to schools teaching “radical gender ideology” and barring “men from women's spaces” (Trump, <span>n.d.</span>). He was recently quoted saying, “It will be the policy of the United States that there are only two genders, male and female” (Monteil, <span>2024</span>). An upcoming Supreme Court decision (United States v. Skrmetti, Docket No. 23–477, <span>2024–2025</span>) will decide whether st
{"title":"Navigating sexual orientation and gender identity data privacy concerns in United States genetics practices","authors":"Kimberly Zayhowski,&nbsp;Sarah Roth,&nbsp;M. J. Westerfield,&nbsp;Makenna A. Martin,&nbsp;Kai Blumen,&nbsp;Harris T. Bland,&nbsp;Shelly W. McQuaid,&nbsp;Kathleen F. Mittendorf","doi":"10.1002/jgc4.70008","DOIUrl":"https://doi.org/10.1002/jgc4.70008","url":null,"abstract":"&lt;p&gt;Recent federal efforts, such as those by the Centers for Medicare &amp; Medicaid Services, have expanded sexual orientation and gender identity (SOGI) data collection to improve healthcare equity, and several states mandate regular SOGI data collection in healthcare (examples in Hunter, &lt;span&gt;2021&lt;/span&gt;; Oregon Health Authority, &lt;span&gt;2023&lt;/span&gt;; Tsai, &lt;span&gt;2023&lt;/span&gt;). Best practice recommendations in genetics healthcare also encourage SOGI data collection (Bland et al., &lt;span&gt;2024&lt;/span&gt;; Jamal et al., &lt;span&gt;2024&lt;/span&gt;). SOGI data allow the provision of accurate, culturally responsive genetics care. For example, healthcare professionals' (HCP) knowledge of patients' gender-affirming care facilitates accurate cancer risk assessments and management (Cortina et al., &lt;span&gt;2024&lt;/span&gt;; Roth et al., &lt;span&gt;2024&lt;/span&gt;; von Vaupel-Klein &amp; Walsh, &lt;span&gt;2021&lt;/span&gt;). Moreover, HCPs respecting patients' identities and family structures promotes trust and psychological safety (Call et al., &lt;span&gt;2021&lt;/span&gt;; Huser et al., &lt;span&gt;2022&lt;/span&gt;; McCann &amp; Brown, &lt;span&gt;2018&lt;/span&gt;; Roth et al., &lt;span&gt;2024&lt;/span&gt;).&lt;/p&gt;&lt;p&gt;However, as we enter the second Trump administration, SOGI data documentation has concerning implications in the United States socio-political landscape. The previous Trump administration enacted overtly anti-LGBTQ+ (lesbian, gay, bisexual, transgender, queer/questioning, etc.) policies, including banning transgender and gender diverse (TGD) individuals from military service, attempting to define gender strictly based on sex assigned at birth, and rolling back LGBTQ+ patient protections granted during the Obama administration (Green et al., &lt;span&gt;2018&lt;/span&gt;; Memorandum on Military Service by Transgender Individuals, &lt;span&gt;2017&lt;/span&gt;; Nondiscrimination in Health and Health Education Programs or Activities, Delegation of Authority, 45 CFR 92, &lt;span&gt;2020&lt;/span&gt;). Despite re-expansion of LBGTQ+ federal legislative protections under the Biden administration, far-right anti-LGBTQ+ legislation has increased at the state level (American Civil Liberties Union, &lt;span&gt;2024&lt;/span&gt;; Restar et al., &lt;span&gt;2024&lt;/span&gt;). The 2024 Trump campaign and those of allied Congressional candidates promised additional anti-TGD policies, with Republicans spending over $222 million dollars on anti-TGD and anti-LGBTQ advertisements during this time (Simmons-Duffin, &lt;span&gt;2024&lt;/span&gt;). The Trump administration is expected to prioritize policies targeting TGD individuals early in its tenure, as highlighted in its “Agenda 47” platform, with points including cutting funding to schools teaching “radical gender ideology” and barring “men from women's spaces” (Trump, &lt;span&gt;n.d.&lt;/span&gt;). He was recently quoted saying, “It will be the policy of the United States that there are only two genders, male and female” (Monteil, &lt;span&gt;2024&lt;/span&gt;). An upcoming Supreme Court decision (United States v. Skrmetti, Docket No. 23–477, &lt;span&gt;2024–2025&lt;/span&gt;) will decide whether st","PeriodicalId":54829,"journal":{"name":"Journal of Genetic Counseling","volume":"34 2","pages":""},"PeriodicalIF":1.9,"publicationDate":"2025-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jgc4.70008","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143571214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic testing for children at risk to be hemophilia carriers
IF 1.9 4区 医学 Q3 GENETICS & HEREDITY Pub Date : 2025-03-07 DOI: 10.1002/jgc4.2024
Kristin N. Maher, Katie Bergstrom

Carriers for hemophilia are at risk for bleeding despite normal or mildly reduced factor 8 or factor 9 activity levels. Genetic testing is necessary to determine carrier status in those at risk and early identification of carriers can inform their bleeding risk. The aims of this single-center retrospective study were to determine the uptake of genetic testing in children at risk to be hemophilia carriers and identify barriers to completion of testing. We identified 64 unique at-risk children assigned female sex at birth under 18 years old, with at least one caregiver participating in a visit between June 2019 and July 2023 with a genetic counselor with expertise in hemophilia. Of all those at risk, 27% (17/64) had undergone genetic testing prior to having genetic counseling at our center, at a median age of 5 years. Of those who had not yet had genetic testing (47/64): insurance prior authorization was initiated for 49% (23/47), testing was completed for 28% (13/47) at a median age of 11 years, and factor activity levels were known or drawn after the visit for 36% (17/47). The primary reason (14/24, 58%) for not initiating insurance prior authorization was not having a known family variant. Because carrier testing for X-linked disorders standardly involves targeted family variant testing rather than full gene testing, increasing the accessibility of carrier testing depends on increasing the accessibility and uptake of genetic testing in affected family members, usually individuals assigned male sex at birth, with a diagnosis of hemophilia. The impact of the decision to pursue genetic testing on current or future family members at risk to be carriers could be included in counseling discussions with individuals with hemophilia and their families.

{"title":"Genetic testing for children at risk to be hemophilia carriers","authors":"Kristin N. Maher,&nbsp;Katie Bergstrom","doi":"10.1002/jgc4.2024","DOIUrl":"https://doi.org/10.1002/jgc4.2024","url":null,"abstract":"<p>Carriers for hemophilia are at risk for bleeding despite normal or mildly reduced factor 8 or factor 9 activity levels. Genetic testing is necessary to determine carrier status in those at risk and early identification of carriers can inform their bleeding risk. The aims of this single-center retrospective study were to determine the uptake of genetic testing in children at risk to be hemophilia carriers and identify barriers to completion of testing. We identified 64 unique at-risk children assigned female sex at birth under 18 years old, with at least one caregiver participating in a visit between June 2019 and July 2023 with a genetic counselor with expertise in hemophilia. Of all those at risk, 27% (17/64) had undergone genetic testing prior to having genetic counseling at our center, at a median age of 5 years. Of those who had not yet had genetic testing (47/64): insurance prior authorization was initiated for 49% (23/47), testing was completed for 28% (13/47) at a median age of 11 years, and factor activity levels were known or drawn after the visit for 36% (17/47). The primary reason (14/24, 58%) for not initiating insurance prior authorization was not having a known family variant. Because carrier testing for X-linked disorders standardly involves targeted family variant testing rather than full gene testing, increasing the accessibility of carrier testing depends on increasing the accessibility and uptake of genetic testing in affected family members, usually individuals assigned male sex at birth, with a diagnosis of hemophilia. The impact of the decision to pursue genetic testing on current or future family members at risk to be carriers could be included in counseling discussions with individuals with hemophilia and their families.</p>","PeriodicalId":54829,"journal":{"name":"Journal of Genetic Counseling","volume":"34 2","pages":""},"PeriodicalIF":1.9,"publicationDate":"2025-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143565238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Revision request to the standardized pedigree nomenclature regarding surrogacy versus gestational carriers and suggestion for new nomenclature pertaining to embryo adoption
IF 1.9 4区 医学 Q3 GENETICS & HEREDITY Pub Date : 2025-03-07 DOI: 10.1002/jgc4.2021
Colton Rathbun, Kristin Paulyson Nuñez
{"title":"Revision request to the standardized pedigree nomenclature regarding surrogacy versus gestational carriers and suggestion for new nomenclature pertaining to embryo adoption","authors":"Colton Rathbun,&nbsp;Kristin Paulyson Nuñez","doi":"10.1002/jgc4.2021","DOIUrl":"https://doi.org/10.1002/jgc4.2021","url":null,"abstract":"","PeriodicalId":54829,"journal":{"name":"Journal of Genetic Counseling","volume":"34 2","pages":""},"PeriodicalIF":1.9,"publicationDate":"2025-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143565237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Supervision for genetic counselors: The role of career-long supervision to develop resilient practitioners
IF 1.9 4区 医学 Q3 GENETICS & HEREDITY Pub Date : 2025-02-20 DOI: 10.1002/jgc4.70014
Alison McEwen, Allyson Davys, Jon Weil

Supervision is a professional activity that provides practitioners with opportunities to reflect on, integrate and learn from work experiences, build resilience, and develop and review their professional identity through reflective conversations with a supervisor and/or peers. Supervision involves a contractual agreement between a supervisor and supervisee (practitioner), that recognizes the accountability of the supervision process to professional and organizational standards and protocols. Incorporating supervision into practice for genetic counselors at all career stages provides a way to develop and strengthen competence and practice and support genetic counselor well-being and client safety. Evidence also suggests that active engagement with effective professional supervision reduces the likelihood of burnout in healthcare workers. Genetic counselors in some parts of the world, including Australia, New Zealand, and the United Kingdom, participate in career-long supervision as a requirement of certification and registration. As the genetic counseling profession expands and diversifies, individuals and professional societies are encouraged to embed the practice of supervision beyond graduate training, establishing a professional culture that values career-long facilitated reflection and learning. We propose the establishment of a global genetic counseling supervision community of practice for genetic counselors interested in developing supervision practices and sharing resources.

{"title":"Supervision for genetic counselors: The role of career-long supervision to develop resilient practitioners","authors":"Alison McEwen,&nbsp;Allyson Davys,&nbsp;Jon Weil","doi":"10.1002/jgc4.70014","DOIUrl":"https://doi.org/10.1002/jgc4.70014","url":null,"abstract":"<p>Supervision is a professional activity that provides practitioners with opportunities to reflect on, integrate and learn from work experiences, build resilience, and develop and review their professional identity through reflective conversations with a supervisor and/or peers. Supervision involves a contractual agreement between a supervisor and supervisee (practitioner), that recognizes the accountability of the supervision process to professional and organizational standards and protocols. Incorporating supervision into practice for genetic counselors at all career stages provides a way to develop and strengthen competence and practice and support genetic counselor well-being and client safety. Evidence also suggests that active engagement with effective professional supervision reduces the likelihood of burnout in healthcare workers. Genetic counselors in some parts of the world, including Australia, New Zealand, and the United Kingdom, participate in career-long supervision as a requirement of certification and registration. As the genetic counseling profession expands and diversifies, individuals and professional societies are encouraged to embed the practice of supervision beyond graduate training, establishing a professional culture that values career-long facilitated reflection and learning. We propose the establishment of a global genetic counseling supervision community of practice for genetic counselors interested in developing supervision practices and sharing resources.</p>","PeriodicalId":54829,"journal":{"name":"Journal of Genetic Counseling","volume":"34 1","pages":""},"PeriodicalIF":1.9,"publicationDate":"2025-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jgc4.70014","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143455809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A heartfelt thank you to the 2024 Journal of Genetic Counseling reviewers
IF 1.9 4区 医学 Q3 GENETICS & HEREDITY Pub Date : 2025-02-20 DOI: 10.1002/jgc4.70023
{"title":"A heartfelt thank you to the 2024 Journal of Genetic Counseling reviewers","authors":"","doi":"10.1002/jgc4.70023","DOIUrl":"https://doi.org/10.1002/jgc4.70023","url":null,"abstract":"","PeriodicalId":54829,"journal":{"name":"Journal of Genetic Counseling","volume":"34 1","pages":""},"PeriodicalIF":1.9,"publicationDate":"2025-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143455792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Training for the future of the genetic counseling profession: Exploring the assessment and adaptation of graduate programs' didactic curriculum 未来遗传咨询专业的培训:探索研究生课程教学的评估与适应。
IF 1.9 4区 医学 Q3 GENETICS & HEREDITY Pub Date : 2025-01-19 DOI: 10.1002/jgc4.2023
Anna K. Vercruyssen, Beverly M. Yashar, Caren M. Stalburg, Monica Marvin

Since the first genetic counseling program (GCP) was established in 1969, there has been a proliferation of growth and demand for genetic counselors. Advances in technology, affordable access to genetic testing, public genomic health initiatives, and diversifying clinical and non-clinical roles comprise a dynamic environment that GCPs must respond to. While there is extensive literature regarding how other health professions adapt their curricula to changing environments, this has yet to be documented and explored for genetic counseling. This study aimed to understand how GCPs evolve their didactic curricula to keep up with the rapidly changing professional landscape. An online survey was used to recruit program leadership of fully accredited GCPs for semi-structured interviews. These interviews explored four critical factors of didactic curricular change, including drivers, implementation, barriers, and mechanisms for evaluation after a change has been made. Interview transcripts were analyzed using reflexive thematic analysis based on iterative discussions with prioritization of excerpts from the codes that had been most commonly applied across multiple transcripts. Multiple factors were identified that program leadership must appropriately weigh when making curricular change decisions. The factors that were considered major influences by all participants included national accreditation standards, program stakeholders, sponsoring institutions and local genetic counseling communities, and the genetic counseling profession as a whole. Our data also demonstrated the extensive role program leadership plays in the adaptation of didactic curricula. With GCP leadership constantly identifying, implementing, and evaluating complex didactic curricular change, there is a need for further exploration of this topic and development of genetic counseling specific resources and tools.

自1969年第一个遗传咨询项目(GCP)成立以来,遗传咨询师的增长和需求一直在激增。技术进步、负担得起的基因检测、公共基因组健康倡议以及临床和非临床角色多样化构成了一个动态环境,gcp必须对此作出反应。虽然关于其他卫生专业如何适应不断变化的环境有大量的文献,但这还没有被记录和探索遗传咨询。本研究旨在了解gcp如何发展他们的教学课程,以跟上快速变化的专业景观。一项在线调查被用来招募完全认可的gcp的项目领导进行半结构化面试。这些访谈探讨了教学课程改变的四个关键因素,包括驱动因素、实施、障碍和改变后的评估机制。访谈记录使用反身性主题分析进行分析,该分析基于迭代讨论,并对多个记录中最常用的代码片段进行优先级排序。在做出课程改变的决定时,项目领导必须适当地权衡多个因素。所有参与者认为主要影响因素包括国家认证标准、项目利益相关者、赞助机构和当地遗传咨询社区,以及整个遗传咨询行业。我们的数据还表明,项目领导在教学课程的适应中发挥着广泛的作用。随着GCP领导层不断识别、实施和评估复杂的教学课程变化,有必要进一步探索这一主题,并开发遗传咨询的特定资源和工具。
{"title":"Training for the future of the genetic counseling profession: Exploring the assessment and adaptation of graduate programs' didactic curriculum","authors":"Anna K. Vercruyssen,&nbsp;Beverly M. Yashar,&nbsp;Caren M. Stalburg,&nbsp;Monica Marvin","doi":"10.1002/jgc4.2023","DOIUrl":"10.1002/jgc4.2023","url":null,"abstract":"<p>Since the first genetic counseling program (GCP) was established in 1969, there has been a proliferation of growth and demand for genetic counselors. Advances in technology, affordable access to genetic testing, public genomic health initiatives, and diversifying clinical and non-clinical roles comprise a dynamic environment that GCPs must respond to. While there is extensive literature regarding how other health professions adapt their curricula to changing environments, this has yet to be documented and explored for genetic counseling. This study aimed to understand how GCPs evolve their didactic curricula to keep up with the rapidly changing professional landscape. An online survey was used to recruit program leadership of fully accredited GCPs for semi-structured interviews. These interviews explored four critical factors of didactic curricular change, including drivers, implementation, barriers, and mechanisms for evaluation after a change has been made. Interview transcripts were analyzed using reflexive thematic analysis based on iterative discussions with prioritization of excerpts from the codes that had been most commonly applied across multiple transcripts. Multiple factors were identified that program leadership must appropriately weigh when making curricular change decisions. The factors that were considered major influences by all participants included national accreditation standards, program stakeholders, sponsoring institutions and local genetic counseling communities, and the genetic counseling profession as a whole. Our data also demonstrated the extensive role program leadership plays in the adaptation of didactic curricula. With GCP leadership constantly identifying, implementing, and evaluating complex didactic curricular change, there is a need for further exploration of this topic and development of genetic counseling specific resources and tools.</p>","PeriodicalId":54829,"journal":{"name":"Journal of Genetic Counseling","volume":"34 1","pages":""},"PeriodicalIF":1.9,"publicationDate":"2025-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11744034/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143015973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Practices and perspectives of genetic counselors about high-risk pancreatic cancer screening: A cross-sectional survey study 遗传咨询师在高危胰腺癌筛查中的实践与展望:一项横断面调查研究。
IF 1.9 4区 医学 Q3 GENETICS & HEREDITY Pub Date : 2025-01-15 DOI: 10.1002/jgc4.2016
Amy Wiegand, Ankit Chhoda, Aparna Namboodiri, Alyssa A. Grimshaw, Disha Dalela, James Farrell

Surveillance of individuals at high-risk of pancreatic cancer using CAPS criteria and other expert consensus guidelines may result in earlier pancreatic cancer detection in some cases; therefore, clinicians are responsible for appropriately identifying and referring these individuals to appropriate high-risk pancreas cancer screening programs. This study aimed at assessing the perspective, knowledge, and clinical practices of cancer genetic counselors surveyed nationwide towards identification of individuals at high-risk of pancreatic cancer and utilization of high-risk pancreatic cancer screening programs. One hundred and eighty-nine genetic counselors who listed “Cancer” as their specialty on the NSGC website responded to the survey, which consisted of multiple practice-based, knowledge-based, and clinical vignette-based questions. Almost 70% of the genetic counselors surveyed accurately identified when an individual would be considered for high-risk pancreatic cancer screening, when using 2019 CAPS consensus guidelines as a benchmark. Access to high-risk pancreatic cancer screening programs and increased provider comfort in counseling individuals at high-risk of pancreatic cancer were found to be statistically associated in accurate identification of high-risk individuals in three of the clinical vignettes. Additionally, 60% of genetic counselors reported the majority of high-risk individuals accept a referral for pancreatic cancer screening, which shows a high uptake of patients accepting referrals from genetic counselors. Genetic counselors have high accuracy in determining who is eligible for high-risk pancreas screening; thus, they are the ideal providers for initiating referrals to high-risk pancreatic cancer screening programs. Genetic counseling programs and high-risk pancreatic cancer screening programs should establish a close working relationship to optimize the identification and subsequent referrals of high-risk individuals eligible for pancreas cancer screening.

在某些情况下,使用CAPS标准和其他专家共识指南对胰腺癌高危人群进行监测可能会导致早期发现胰腺癌;因此,临床医生有责任适当地识别并将这些人推荐到适当的高风险胰腺癌筛查项目中。本研究旨在评估全国范围内接受调查的癌症遗传咨询师的观点、知识和临床实践,以识别胰腺癌高危人群和利用高风险胰腺癌筛查项目。189名遗传咨询师在NSGC网站上将“癌症”列为他们的专业,他们对这项调查做出了回应,该调查由多个基于实践、基于知识和基于临床的小问题组成。接受调查的遗传咨询师中,近70%的人在使用2019年CAPS共识指南作为基准时,准确地确定了一个人何时会被考虑进行高风险胰腺癌筛查。在三个临床小调查中发现,获得高危胰腺癌筛查项目和增加提供者对高危胰腺癌患者的咨询舒适度与准确识别高危个体在统计学上相关。此外,60%的遗传咨询师报告说,大多数高风险个体接受胰腺癌筛查的转诊,这表明接受遗传咨询师转诊的患者比例很高。遗传咨询师在确定谁有资格进行高风险胰腺筛查方面具有很高的准确性;因此,他们是开始转介高危胰腺癌筛查项目的理想提供者。遗传咨询项目和高风险胰腺癌筛查项目应建立密切的工作关系,以优化胰腺癌筛查高危人群的识别和后续转诊。
{"title":"Practices and perspectives of genetic counselors about high-risk pancreatic cancer screening: A cross-sectional survey study","authors":"Amy Wiegand,&nbsp;Ankit Chhoda,&nbsp;Aparna Namboodiri,&nbsp;Alyssa A. Grimshaw,&nbsp;Disha Dalela,&nbsp;James Farrell","doi":"10.1002/jgc4.2016","DOIUrl":"10.1002/jgc4.2016","url":null,"abstract":"<p>Surveillance of individuals at high-risk of pancreatic cancer using CAPS criteria and other expert consensus guidelines may result in earlier pancreatic cancer detection in some cases; therefore, clinicians are responsible for appropriately identifying and referring these individuals to appropriate high-risk pancreas cancer screening programs. This study aimed at assessing the perspective, knowledge, and clinical practices of cancer genetic counselors surveyed nationwide towards identification of individuals at high-risk of pancreatic cancer and utilization of high-risk pancreatic cancer screening programs. One hundred and eighty-nine genetic counselors who listed “Cancer” as their specialty on the NSGC website responded to the survey, which consisted of multiple practice-based, knowledge-based, and clinical vignette-based questions. Almost 70% of the genetic counselors surveyed accurately identified when an individual would be considered for high-risk pancreatic cancer screening, when using 2019 CAPS consensus guidelines as a benchmark. Access to high-risk pancreatic cancer screening programs and increased provider comfort in counseling individuals at high-risk of pancreatic cancer were found to be statistically associated in accurate identification of high-risk individuals in three of the clinical vignettes. Additionally, 60% of genetic counselors reported the majority of high-risk individuals accept a referral for pancreatic cancer screening, which shows a high uptake of patients accepting referrals from genetic counselors. Genetic counselors have high accuracy in determining who is eligible for high-risk pancreas screening; thus, they are the ideal providers for initiating referrals to high-risk pancreatic cancer screening programs. Genetic counseling programs and high-risk pancreatic cancer screening programs should establish a close working relationship to optimize the identification and subsequent referrals of high-risk individuals eligible for pancreas cancer screening.</p>","PeriodicalId":54829,"journal":{"name":"Journal of Genetic Counseling","volume":"34 1","pages":""},"PeriodicalIF":1.9,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jgc4.2016","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143016034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The experience of “at-risk” status for familial frontotemporal dementia (fFTD) and its impact on reproductive decision-making: A qualitative study 家族性额颞叶痴呆(fFTD)“危险”状态的经历及其对生殖决策的影响:一项定性研究。
IF 1.9 4区 医学 Q3 GENETICS & HEREDITY Pub Date : 2025-01-12 DOI: 10.1002/jgc4.2000
Neil Fahy, Oliver S. Hayes, Caroline V. Greaves, Sophie E. Goldsmith, Emilie V. Brotherhood, Jonathan D. Rohrer, Emma Harding, Joshua Stott

Familial frontotemporal dementia (fFTD) is an autosomal dominant heritable form of FTD, onsetting in mid-life, characterized by behavioral and personality changes. Children of an affected parent are at 50% risk of inheriting the relevant fFTD gene variant and developing FTD. Genetic testing means a growing group of people are aware of or considering learning their risk status. This knowledge, combined with witnessing parents' symptoms, has implications for reproduction. This study explores attitudes and approaches to reproductive decision-making among those at risk for fFTD. Thirteen qualitative interviews were conducted with at-risk individuals, including parents and non-parents, and analyzed using Thematic Analysis to explore experiences of at-risk relatives of people with symptomatic FTD, attitudes toward reproductive decision-making, and, among parents, influences of genetic risk status on parenting. The themes identified were: (1) Fear of repetition of own experience with symptomatic relatives; (2) Approaches to mitigating repetition; (3) Responses to genetic risk in reproductive decision-making; (4) Accounting for timing in reproductive decision-making; (5) Challenges of disclosing genetic risk to children; (6) Other mitigating factors in reproductive decision-making. Findings highlight the key role of previous experiences with symptomatic relatives in shaping attitudes toward genetic risk status and approaches to managing it in reproductive decision-making. Findings highlight a need for responsive genetic counseling focused on exploring options alongside providing information and signposting to practical legal and financial support. Future research should specifically compare experiences in fFTD with experiences in other heritable neurodegenerative disorders and explore reproductive decision-making for couples where one partner is at risk of fFTD.

家族性额颞叶痴呆(fFTD)是一种常染色体显性遗传形式的额颞叶痴呆,发病于中年,以行为和人格改变为特征。患病父母的子女遗传相关fFTD基因变异并发展为FTD的风险为50%。基因检测意味着越来越多的人意识到或考虑了解自己的风险状况。这些知识,加上目睹父母的症状,对生殖有影响。本研究探讨了fFTD高危人群对生殖决策的态度和方法。本研究对13名有患病风险的个体(包括父母和非父母)进行了定性访谈,并使用主题分析方法来探讨有症状的FTD患者的有患病风险亲属的经历、对生育决策的态度,以及父母中遗传风险状况对养育子女的影响。确定的主题是:(1)害怕与有症状的亲属重复自己的经历;(2)减少重复的方法;(3)生殖决策中对遗传风险的反应;(4)考虑生育决策的时机;(5)向儿童披露遗传风险的挑战;(六)生育决策中的其他减轻因素。研究结果强调了以往有症状亲属的经历在塑造对遗传风险状况的态度和在生殖决策中管理遗传风险的方法方面的关键作用。研究结果强调了响应性遗传咨询的必要性,重点是探索各种选择,同时为实际的法律和财政支持提供信息和指示。未来的研究应专门比较fFTD与其他遗传性神经退行性疾病的经历,并探讨一方有fFTD风险的夫妇的生殖决策。
{"title":"The experience of “at-risk” status for familial frontotemporal dementia (fFTD) and its impact on reproductive decision-making: A qualitative study","authors":"Neil Fahy,&nbsp;Oliver S. Hayes,&nbsp;Caroline V. Greaves,&nbsp;Sophie E. Goldsmith,&nbsp;Emilie V. Brotherhood,&nbsp;Jonathan D. Rohrer,&nbsp;Emma Harding,&nbsp;Joshua Stott","doi":"10.1002/jgc4.2000","DOIUrl":"10.1002/jgc4.2000","url":null,"abstract":"<p>Familial frontotemporal dementia (fFTD) is an autosomal dominant heritable form of FTD, onsetting in mid-life, characterized by behavioral and personality changes. Children of an affected parent are at 50% risk of inheriting the relevant fFTD gene variant and developing FTD. Genetic testing means a growing group of people are aware of or considering learning their risk status. This knowledge, combined with witnessing parents' symptoms, has implications for reproduction. This study explores attitudes and approaches to reproductive decision-making among those at risk for fFTD. Thirteen qualitative interviews were conducted with at-risk individuals, including parents and non-parents, and analyzed using Thematic Analysis to explore experiences of at-risk relatives of people with symptomatic FTD, attitudes toward reproductive decision-making, and, among parents, influences of genetic risk status on parenting. The themes identified were: (1) Fear of repetition of own experience with symptomatic relatives; (2) Approaches to mitigating repetition; (3) Responses to genetic risk in reproductive decision-making; (4) Accounting for timing in reproductive decision-making; (5) Challenges of disclosing genetic risk to children; (6) Other mitigating factors in reproductive decision-making. Findings highlight the key role of previous experiences with symptomatic relatives in shaping attitudes toward genetic risk status and approaches to managing it in reproductive decision-making. Findings highlight a need for responsive genetic counseling focused on exploring options alongside providing information and signposting to practical legal and financial support. Future research should specifically compare experiences in fFTD with experiences in other heritable neurodegenerative disorders and explore reproductive decision-making for couples where one partner is at risk of fFTD.</p>","PeriodicalId":54829,"journal":{"name":"Journal of Genetic Counseling","volume":"34 1","pages":""},"PeriodicalIF":1.9,"publicationDate":"2025-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11725773/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142973390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of the RIME framework in genetic counseling fieldwork training to assess practice-based competencies. 应用RIME框架在遗传咨询实地工作培训,以评估基于实践的能力。
IF 1.9 4区 医学 Q3 GENETICS & HEREDITY Pub Date : 2024-12-12 DOI: 10.1002/jgc4.2007
Deborah Cragun, Angela Trepanier, Nevena Krstić, Melissa Racobaldo, Paige Hunt, Susan Randall Armel

Using educational frameworks for learner assessment in genetic counseling (GC) training may help students and supervisors articulate developmentally appropriate clinical skills-based objectives and tasks that align with various stages of training as students work toward achieving entry-level competency. This professional issues case study describes how two GC programs adapted and implemented the RIME (Reporter-Interpreter-Manager-Educator) learner assessment framework, originally designed for medical education, to support and assess students' acquisition of practice-based competencies (PBCs) during clinical fieldwork placements. Each RIME level describes a different set of expectations regarding the skills students should be able to demonstrate based on the level of training they have achieved up to that point in time. In early training, students work mainly on gathering and reporting clinical information (Reporter level). In early to mid-training, students have learned what information to collect from clients and begin to apply the information to generate differential diagnoses (Interpreter level). When students reach the Manager level (typically by mid- to late-training), they can independently develop and implement case management plans tailored to individual cases. The Educator level, which may not be fully attained until after graduation, involves critically evaluating evidence and educating others about new evidence. The following paper describes our experiences incorporating the RIME framework into two GC graduate programs and explains the development of corresponding RIME-based assessment forms that align with the Accreditation Council of Genetic Counseling's 2023 PBCs. Overall, we find that using the RIME framework fosters a growth mindset by enabling students and supervisors to create developmentally appropriate goals and expectations, thereby facilitating assessment and guidance of trainee progress. Despite these perceived benefits, we acknowledge the need for research to evaluate the efficacy of the RIME framework or other learner assessment models in supporting student progression in achieving the GC PBCs.

在遗传咨询(GC)培训中使用教育框架对学习者进行评估,可以帮助学生和导师明确发展适当的基于临床技能的目标和任务,这些目标和任务与学生努力实现入门级能力的各个培训阶段相一致。本专业问题案例研究描述了两个GC项目如何适应和实施最初为医学教育设计的RIME(报告者-口译者-管理者-教育者)学习者评估框架,以支持和评估学生在临床实地工作实习期间获得的实践能力(pbc)。每个RIME级别都描述了一组不同的期望,这些期望是关于学生应该能够根据他们在该时间点所获得的培训水平来展示的技能。在早期培训中,学生主要从事临床信息的收集和报告(报告者水平)。在早期到中期的培训中,学生已经学会了从客户那里收集什么信息,并开始应用这些信息来产生鉴别诊断(口译水平)。当学生达到经理级别时(通常通过中后期培训),他们可以独立制定和实施针对个别案例的案例管理计划。教育者水平,可能要到毕业后才能完全达到,包括批判性地评估证据和教育他人新的证据。下面的论文描述了我们将RIME框架纳入两个GC研究生项目的经验,并解释了与遗传咨询认证委员会2023 PBCs一致的相应的基于RIME的评估表格的开发。总的来说,我们发现使用RIME框架可以帮助学生和主管制定适合他们发展的目标和期望,从而促进对学员进步的评估和指导,从而培养一种成长型思维模式。尽管有这些明显的好处,我们承认需要进行研究来评估RIME框架或其他学习者评估模型在支持学生实现GC pbc进展方面的有效性。
{"title":"Application of the RIME framework in genetic counseling fieldwork training to assess practice-based competencies.","authors":"Deborah Cragun, Angela Trepanier, Nevena Krstić, Melissa Racobaldo, Paige Hunt, Susan Randall Armel","doi":"10.1002/jgc4.2007","DOIUrl":"https://doi.org/10.1002/jgc4.2007","url":null,"abstract":"<p><p>Using educational frameworks for learner assessment in genetic counseling (GC) training may help students and supervisors articulate developmentally appropriate clinical skills-based objectives and tasks that align with various stages of training as students work toward achieving entry-level competency. This professional issues case study describes how two GC programs adapted and implemented the RIME (Reporter-Interpreter-Manager-Educator) learner assessment framework, originally designed for medical education, to support and assess students' acquisition of practice-based competencies (PBCs) during clinical fieldwork placements. Each RIME level describes a different set of expectations regarding the skills students should be able to demonstrate based on the level of training they have achieved up to that point in time. In early training, students work mainly on gathering and reporting clinical information (Reporter level). In early to mid-training, students have learned what information to collect from clients and begin to apply the information to generate differential diagnoses (Interpreter level). When students reach the Manager level (typically by mid- to late-training), they can independently develop and implement case management plans tailored to individual cases. The Educator level, which may not be fully attained until after graduation, involves critically evaluating evidence and educating others about new evidence. The following paper describes our experiences incorporating the RIME framework into two GC graduate programs and explains the development of corresponding RIME-based assessment forms that align with the Accreditation Council of Genetic Counseling's 2023 PBCs. Overall, we find that using the RIME framework fosters a growth mindset by enabling students and supervisors to create developmentally appropriate goals and expectations, thereby facilitating assessment and guidance of trainee progress. Despite these perceived benefits, we acknowledge the need for research to evaluate the efficacy of the RIME framework or other learner assessment models in supporting student progression in achieving the GC PBCs.</p>","PeriodicalId":54829,"journal":{"name":"Journal of Genetic Counseling","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142815013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating genetic counseling session duration: A scoping review of patient care time, influencing factors, and impact on patient outcomes. 评估遗传咨询会议持续时间:患者护理时间,影响因素和对患者结果的影响的范围审查。
IF 1.9 4区 医学 Q3 GENETICS & HEREDITY Pub Date : 2024-12-11 DOI: 10.1002/jgc4.1999
Emily Glanton, Megan Kocher, Molly Bostrom, Brady Erlandson, Heather Zierhut

One key element of evaluating the quality of a genetic counseling session is the measurement of its efficiency, yet limited research exists on how the genetic counseling process relates to time and which elements contribute to improved quality of care. A scoping review was undertaken to document studies that have reported genetic counseling patient care time and provide a landscape of the average patient care time, which factors impact patient care time, and how patient care time relates to experiences and outcomes. Twenty-five studies met criteria and were included. Patient care time was reported variably among the studies included. On average, genetic counseling patient care time was a mean of 60 min (53 min median) for observational studies and control groups in experimental studies and 44 min (41 min median) for intervention groups in experimental studies. Interventions impacting patient care time included pre-genetic counseling education and group genetic counseling sessions. The impact of patient care time on patient experiences and outcomes was rarely evaluated, and therefore, efficiency could not often be assessed in the studies. Studies that reported on patient care time and outcomes were able to draw conclusions such as shorter time did not negatively impact patients and some groups of patients may benefit from longer sessions. Most studies did not analyze the relationship between patient care time and patient experiences or outcomes. Future research should aim to identify factors influencing patient care time, assess the content of genetic counseling sessions, and evaluate patient care time in relation to patient experiences and outcomes. Understanding these aspects could lead to improved efficiency and patient-centered, equitable care in genetic counseling practices.

评估遗传咨询会议质量的一个关键因素是测量其效率,然而,关于遗传咨询过程与时间的关系以及哪些因素有助于提高护理质量的研究有限。我们进行了一项范围审查,以记录有关遗传咨询患者护理时间的研究,并提供了平均患者护理时间的概况,哪些因素影响患者护理时间,以及患者护理时间与经验和结果之间的关系。25项研究符合标准并纳入。在纳入的研究中,患者护理时间的报告各不相同。在实验研究中,观察组和对照组的遗传咨询患者护理时间平均为60分钟(中位53分钟),在实验研究中,干预组的遗传咨询患者护理时间平均为44分钟(中位41分钟)。影响患者护理时间的干预措施包括遗传前咨询教育和群体遗传咨询会议。患者护理时间对患者体验和结果的影响很少被评估,因此,在研究中通常无法评估效率。关于患者护理时间和结果的研究报告能够得出结论,例如较短的时间对患者没有负面影响,某些患者组可能从较长的时间中受益。大多数研究没有分析患者护理时间与患者经历或结果之间的关系。未来的研究应旨在确定影响患者护理时间的因素,评估遗传咨询会议的内容,并评估患者护理时间与患者经历和结果的关系。了解这些方面可以导致提高效率和病人为中心,公平护理遗传咨询实践。
{"title":"Evaluating genetic counseling session duration: A scoping review of patient care time, influencing factors, and impact on patient outcomes.","authors":"Emily Glanton, Megan Kocher, Molly Bostrom, Brady Erlandson, Heather Zierhut","doi":"10.1002/jgc4.1999","DOIUrl":"10.1002/jgc4.1999","url":null,"abstract":"<p><p>One key element of evaluating the quality of a genetic counseling session is the measurement of its efficiency, yet limited research exists on how the genetic counseling process relates to time and which elements contribute to improved quality of care. A scoping review was undertaken to document studies that have reported genetic counseling patient care time and provide a landscape of the average patient care time, which factors impact patient care time, and how patient care time relates to experiences and outcomes. Twenty-five studies met criteria and were included. Patient care time was reported variably among the studies included. On average, genetic counseling patient care time was a mean of 60 min (53 min median) for observational studies and control groups in experimental studies and 44 min (41 min median) for intervention groups in experimental studies. Interventions impacting patient care time included pre-genetic counseling education and group genetic counseling sessions. The impact of patient care time on patient experiences and outcomes was rarely evaluated, and therefore, efficiency could not often be assessed in the studies. Studies that reported on patient care time and outcomes were able to draw conclusions such as shorter time did not negatively impact patients and some groups of patients may benefit from longer sessions. Most studies did not analyze the relationship between patient care time and patient experiences or outcomes. Future research should aim to identify factors influencing patient care time, assess the content of genetic counseling sessions, and evaluate patient care time in relation to patient experiences and outcomes. Understanding these aspects could lead to improved efficiency and patient-centered, equitable care in genetic counseling practices.</p>","PeriodicalId":54829,"journal":{"name":"Journal of Genetic Counseling","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2024-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142815014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Genetic Counseling
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1